Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show

Gamida Cell to Present at the Solebury Trout Class of 2018 Biotech IPOs Investor Day


Gamida Cell Ltd. (Nasdaq: GMDA), a leading cellular and immune therapeutics company, today announced that Julian Adams, Ph.D., the company's chief executive officer, will present an overview of the company at the Solebury Trout Class of 2018 Biotech IPOs Investor Day on Friday, April 26, 2019, at 2:30 p.m. ET in New York City. The conference is hosted by Davis Polk and BMO Capital Markets.

A live webcast of the presentation will be available on the Investors section of the Gamida Cell website, www.gamida-cell.com, and will be available for at least 30 days following the event.

About Gamida Cell
Gamida Cell is a clinical-stage biopharmaceutical company committed to developing advanced cell therapies with the potential to cure blood cancers and rare, serious hematologic diseases. We are leveraging our proprietary nicotinamide-based, or NAM-based, cell expansion technology to develop product candidates designed to address the limitations of cell therapies. For additional information, please visit www.gamida-cell.com.


These press releases may also interest you

at 06:35
Materialise NV , a leading provider of additive manufacturing and medical software and of sophisticated 3D printing services, today announced its financial results for the first quarter ended March 31, 2024. Highlights ? First Quarter 2024 Total...

at 06:35
Merck , known as MSD outside the United States and Canada, today announced financial results for the first quarter of 2024. "Merck has begun 2024 with continuing momentum in our business. We are harnessing the power of innovation to advance our...

at 06:35
Strategic Education, Inc. (Strategic Education) today announced financial results for the period ended March 31, 2024. "As we begin a new year, we are pleased with strength across our business and proud of the organization's ongoing commitment to...

at 06:35
Sage Therapeutics, Inc. , a biopharmaceutical company leading the way to create a world with better brain health, today reported business highlights and financial results for the first quarter ended March 31, 2024. "The launch of ZURZUVAE is off to...

at 06:35
The time it takes to deploy new value-added services for broadband customers has been drastically reduced from months to weeks opening the door to delivering an app-store-like experience via broadband routers. Value-added services like...

at 06:30
Congruent Solutions, a leading provider of Software-as-a-Service (SaaS) and outsourced plan administration services to the retirement industry in the U.S., today announced the appointment of Mahesh Natarajan as its Chief Revenue Officer. Natarajan...



News published on and distributed by: